CCM
GILD icon

Catalio Capital Management’s Gilead Sciences GILD Stock Holding History

Catalio Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34M Buy
269,309
+105,404
+64% +$13.9M 6.39% 3
2026
Q1 		$22.8M Sell
163,905
-125,407
-43% -$17.6M 4.77% 6
2025
Q4 		$35.5M Buy
+289,312
New +$35.2M 6.28% 1
2025
Q3 		– Sell
-226,875
Closed -$25.2M – 42
2025
Q2 		$25.2M Buy
+226,875
New +$24.1M 5.27% 7

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Catalio Capital Management's GILD Position: Q2 2026 in Review

Catalio Capital Management increased its Gilead Sciences (GILD) stake by 64% in Q2 2026, buying an estimated $13.9M and bringing the position to 269,309 shares worth $34M. The position accounts for 6.39% of the portfolio, ranked #3.

Catalio Capital Management first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $35.5M in Q4 2025. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Catalio Capital Management held 269,309 shares of Gilead Sciences worth $34M as of Q2 2026.
  • Catalio Capital Management bought 105,404 Gilead Sciences shares in Q2 2026, an estimated $13.9M.
  • Gilead Sciences made up 6.39% of Catalio Capital Management's portfolio in Q2 2026, its #3 holding.
  • Catalio Capital Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • Catalio Capital Management's Gilead Sciences position peaked at $35.5M in Q4 2025.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Catalio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.